Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Aoyama

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Internal Medicine (Tokyo, Japan)|June 28, 2026
A Case of Transient ACTH and Cortisol Suppression Caused by Dexamethasone Mouthwash during Immune Checkpoint Inhibitor TreatmentYosuke Aoyama, Yurie Haruyama, Yukinori Ozaki, et al.
Medicine|October 12, 2022
Primary bronchial schwannoma: A case reportYosuke Aoyama, Atsushi Miyamoto, Takeshi Fujii, et al.
JCO Clinical Cancer Informatics|November 23, 2022
Efficacy of Telemedicine Using Videoconferencing Systems in Outpatient Care for Patients With Cancer: A Systematic Review and Meta-AnalysisYasuaki Uemoto, Taro Yamanaka, Yuki Kataoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2020
[Malignant Spinal Cord Compression]Yosuke Aoyama, Chihiro Kondoh, Masato Anno, et al.
BMC Cancer|September 17, 2024
Absolute lymphocyte count predicts efficacy of palbociclib in patients with metastatic luminal breast cancerTakayuki Kobayashi, Meiko Nishimura, Mari Hosonaga, et al.
Breast Disease|December 5, 2025
Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapyMeiko Nishimura, Takayuki Kobayashi, Yosuke Aoyama, et al.
Rheumatology (Oxford, England)|December 14, 2025
Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohortYuka Morita, Koichi Takeda, Hiroki Osumi, et al.
Breast Cancer (Tokyo, Japan)|December 7, 2024
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world studyYosuke Aoyama, Yukinori Ozaki, Rika Kizawa, et al.
BMC Cancer|January 5, 2022
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center studyYukinori Ozaki, Yosuke Aoyama, Jun Masuda, et al.
Breast Cancer (Tokyo, Japan)|December 11, 2023
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress ScaleYosuke Aoyama, Eri Hoshino, Akihiko Shimomura, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Internal Medicine (Tokyo, Japan)|June 28, 2026
A Case of Transient ACTH and Cortisol Suppression Caused by Dexamethasone Mouthwash during Immune Checkpoint Inhibitor TreatmentYosuke Aoyama, Yurie Haruyama, Yukinori Ozaki, et al.
Medicine|October 12, 2022
Primary bronchial schwannoma: A case reportYosuke Aoyama, Atsushi Miyamoto, Takeshi Fujii, et al.
JCO Clinical Cancer Informatics|November 23, 2022
Efficacy of Telemedicine Using Videoconferencing Systems in Outpatient Care for Patients With Cancer: A Systematic Review and Meta-AnalysisYasuaki Uemoto, Taro Yamanaka, Yuki Kataoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2020
[Malignant Spinal Cord Compression]Yosuke Aoyama, Chihiro Kondoh, Masato Anno, et al.
BMC Cancer|September 17, 2024
Absolute lymphocyte count predicts efficacy of palbociclib in patients with metastatic luminal breast cancerTakayuki Kobayashi, Meiko Nishimura, Mari Hosonaga, et al.
Breast Disease|December 5, 2025
Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapyMeiko Nishimura, Takayuki Kobayashi, Yosuke Aoyama, et al.
Rheumatology (Oxford, England)|December 14, 2025
Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohortYuka Morita, Koichi Takeda, Hiroki Osumi, et al.
Breast Cancer (Tokyo, Japan)|December 7, 2024
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world studyYosuke Aoyama, Yukinori Ozaki, Rika Kizawa, et al.
BMC Cancer|January 5, 2022
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center studyYukinori Ozaki, Yosuke Aoyama, Jun Masuda, et al.
Breast Cancer (Tokyo, Japan)|December 11, 2023
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress ScaleYosuke Aoyama, Eri Hoshino, Akihiko Shimomura, et al.
Pageof 1